205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.34%
Revenue growth 1.25-1.5x ADI's 0.98%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
0.45%
Gross profit growth under 50% of ADI's 2.61%. Michael Burry would be concerned about a severe competitive disadvantage.
-9.38%
Negative EBIT growth while ADI is at 16.90%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.38%
Negative operating income growth while ADI is at 16.90%. Joel Greenblatt would press for urgent turnaround measures.
-20.83%
Negative net income growth while ADI stands at 28.21%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-20.00%
Negative EPS growth while ADI is at 100.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while ADI is at 100.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-4.76%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-3.40%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
131.58%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
319.57%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
59.17%
10Y revenue/share CAGR at 75-90% of ADI's 69.45%. Bill Ackman would press for new markets or product lines to narrow the gap.
38.19%
5Y revenue/share CAGR at 50-75% of ADI's 58.45%. Martin Whitman would worry about a lagging mid-term growth trajectory.
13.96%
3Y revenue/share CAGR under 50% of ADI's 30.76%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
168.99%
10Y net income/share CAGR of 168.99% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
5.29%
Net income/share CAGR of 5.29% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-18.74%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.02%
Negative 3Y equity/share growth while ADI is at 2.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
70.37%
Dividend/share CAGR of 70.37% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
70.37%
3Y dividend/share CAGR of 70.37% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-2.63%
Firm’s AR is declining while ADI shows 13.72%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.72%
Inventory is declining while ADI stands at 4.10%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.81%
Asset growth well under 50% of ADI's 4.16%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
7.09%
Under 50% of ADI's 16.62%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.06%
We’re deleveraging while ADI stands at 8.44%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
4.36%
SG&A growth well above ADI's 0.67%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.